Overview

Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid

Status:
Active, not recruiting

Trial end date:
2021-09-01

Target enrollment:

Participant gender:

Summary

The purpose of the proposed study is to evaluate the effects of administering intravenous tranexamic acid (TXA) to patients undergoing tibial tubercle osteotomy (TTO) to minimize hemarthrosis within the knee joint and post-operative pain.

Phase:

Phase 4

Details

Lead Sponsor:

New York University School of Medicine
NYU Langone Health

Treatments:

Tranexamic Acid